share_log

CNS Pharmaceuticals | 8-K: CNS Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

SEC ·  Aug 15, 2022 21:09
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more